← Back to Patent Explorer
US5254342A Expired / Lapsed US ⏱️ 0.0 years remaining

Compositions and methods for enhanced transepithelial and transendothelial transport or active agents

Assignee: University of Southern California
•
Filing: 1991-09-30
•
Granted: 1993-10-19
•
Expires: 2011-09-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compositions and methods for use in enhancement of transmembrane and transcellular transport of an active agent, in particular a peptide or protein, in which at least one carrier for transmembrane or transcellular transport of an active agent which is a ligand for a cell-surface receptor is used to form a ligand/active agent conjugate and at least one transfer enhancement agent which enhances transcytosis of the resultant cell-surface receptor/ligand complex is administered to accelerate transcytosis. As an example, the effects of brefeldin A and monensin on transferrin (Tf) transcellular transport, Tf receptor (TfR) distribution and TfR-mediated endocytosis in filter-grown MDCK cells are described. The transfer enhancement agents markedly enhanced the transcytosis of ligand/active agent complexes in both the apical-to-basal and the basal-to-apical directions, but did not increase the transcytosis of agents which were not bound to a cell-surface receptor ligand as carrier. Furthermore, this enhanced transcytosis was abolished by competition with excess unlabeled Tf, confirming that it was a TfR-mediated process.

Inventors

  • 👤 Wei-Chiang Shen
  • 👤 Jiansheng Wan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 04:36
CPC Classifications
A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/62; A61K47/64; A61K47/644

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 53 words
A method for enhancing transcellular or transmembrane transport of an active agent, said method comprising: forming a conjugate of said active agent with a cell-surface receptor ligand for a transferrin receptor; and administering said conjugate and a transfer enhancing amount of a transfer enhancement agent which enhances transcytosis of a cell-surface receptor/ligand complex.
Claim 2
Independent Claim 53 words
A method for enhancing transcellular or transmembrane transport of an active agent, said method comprising: forming a conjugate of said active agent with a cell-surface receptor ligand for a transferrin receptor; and administering said conjugate and a transfer enhancing amount of a transfer enhancement agent which enhances transcytosis of a cell-surface receptor/ligand complex.
Claim 3
Dependent Claim 16 words
A method according to claim 1, wherein said transfer enhancement agent is brefeldin A or monensin.

References Cited (Backward Citations)

US5108921A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-10-18 1997-04-19 1997-10-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-10-18 2001-04-19 2001-10-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-10-18 2005-04-19 2005-10-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag